HSE approves Skyclarys reimbursement for Friedreich's Ataxia patients
25 August - 17 mins
Podcast Series
The Hard Shoulder
The HSE has approved the reimbursement of the drug Skyclarys for people with Friedreich's Ataxia.
This comes following a substantially improved financial offer by drug firm Biogen to the Health Service Executive.
Joining Ciara to discuss this is Minister for Health, Jennifer Carroll MacNeill.
Series Episodes
